Literature DB >> 16582540

Rac2 concentrations in umbilical cord neutrophils.

Virginia M Meade1, Cecilia N Barese, Chaekyun Kim, Charles G Njinimbam, Christophe C Marchal, David A Ingram, D Wade Clapp, Mary C Dinauer, Mervin C Yoder.   

Abstract

BACKGROUND: Human newborn infants display a variety of immunodeficiencies of immaturity, including diminished neutrophil adhesion, chemotaxis, and migration. Rac2, a guanosine triphosphate-binding protein, is an essential regulator of human neutrophil migration and chemotaxis. Since human subjects and mice deficient in Rac2 display deficiencies in neutrophil functions similar to newborn infants, we postulated that newborn neutrophils may be deficient in Rac2.
OBJECTIVES: The aim of the study was to measure Rac1 and Rac2 concentrations in neutrophils from umbilical cord blood.
METHODS: Neutrophils from cord and adult blood were isolated, total cell lysates extracted, and Rac protein concentrations determined using Western blot analysis.
RESULTS: Rac2 concentrations were significantly lower in the neutrophil protein lysates isolated from cord blood compared to adult blood despite similar levels of Rac1.
CONCLUSIONS: Diminished Rac2 expression in cord blood neutrophils may contribute to the defects observed in cord blood neutrophil function. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582540     DOI: 10.1159/000092451

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  3 in total

Review 1.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 2.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 3.  Dysfunction of innate immunity and associated pathology in neonates.

Authors:  Anna Petrova; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 5.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.